Subscribe
dna-istock-518143098-ralwel--2
ralwel / iStockphoto.com
26 March 2020Genetics

Webinar: Plenty to fight for in CRISPR IP battle

Despite a recent swing in momentum to the University of California (UC), it’s still too early to say who is likely to emerge triumphant in the CRISPR patent battle.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
Webinar: How do you patent healthcare AI?
28 April 2020   Judging by today’s news cycle, you might think that the world of IP is quite advanced when it comes to artificial intelligence .
Biotechnology
LSPN Connect: Eldora Ellison on PTAB denials, CRISPR and section 101
28 October 2020   Discretionary denials at the Patent Trial and Appeal Board, the CRISPR landscape and section 101 are top of mind for Eldora Ellison, director at Sterne Kessler Goldstein & Fox.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Europe
Webinar: How do you patent healthcare AI?
28 April 2020   Judging by today’s news cycle, you might think that the world of IP is quite advanced when it comes to artificial intelligence .
Biotechnology
LSPN Connect: Eldora Ellison on PTAB denials, CRISPR and section 101
28 October 2020   Discretionary denials at the Patent Trial and Appeal Board, the CRISPR landscape and section 101 are top of mind for Eldora Ellison, director at Sterne Kessler Goldstein & Fox.

More on this story

Europe
Webinar: How do you patent healthcare AI?
28 April 2020   Judging by today’s news cycle, you might think that the world of IP is quite advanced when it comes to artificial intelligence .
Biotechnology
LSPN Connect: Eldora Ellison on PTAB denials, CRISPR and section 101
28 October 2020   Discretionary denials at the Patent Trial and Appeal Board, the CRISPR landscape and section 101 are top of mind for Eldora Ellison, director at Sterne Kessler Goldstein & Fox.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility